Hemorheologic profile of hyperlipidemic patients treated with gemfibrozil
Open Access
- 31 May 1996
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 57 (5) , 327-335
- https://doi.org/10.1016/s0011-393x(96)80041-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation, 1991
- Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.Circulation, 1990
- Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patientsAtherosclerosis, 1988
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- INCREASED BLOOD VISCOSITY AND FIBRINOLYTIC INHIBITOR IN TYPE II HYPERLIPOPROTEINAEMIAThe Lancet, 1982
- Effects of lipoproteins on plasma viscosityAtherosclerosis, 1981
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Studies of plasma viscosity in primary hyperlipoproteinaemiaAtherosclerosis, 1977
- Effect of Clofibrate on Blood Viscosity in Intermittent ClaudicationBMJ, 1974